BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 17627674)

  • 1. Ethosuximide: from bench to bedside.
    Gören MZ; Onat F
    CNS Drug Rev; 2007; 13(2):224-39. PubMed ID: 17627674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolated P/Q Calcium Channel Deletion in Layer VI Corticothalamic Neurons Generates Absence Epilepsy.
    Bomben VC; Aiba I; Qian J; Mark MD; Herlitze S; Noebels JL
    J Neurosci; 2016 Jan; 36(2):405-18. PubMed ID: 26758833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific petit mal anticonvulsants reduce calcium currents in thalamic neurons.
    Coulter DA; Huguenard JR; Prince DA
    Neurosci Lett; 1989 Mar; 98(1):74-8. PubMed ID: 2710401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethosuximide and bicuculline inhibition in petit mal epilepsy.
    Englander RN; Johnson RN; Hanna GR
    Neurol Neurocir Psiquiatr; 1977; 18(2-3 Suppl):265-75. PubMed ID: 99676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-current related effects of antiepileptic drugs and a Ca2+ channel antagonist on thalamic relay and local circuit interneurons in a rat model of absence epilepsy.
    Broicher T; Seidenbecher T; Meuth P; Munsch T; Meuth SG; Kanyshkova T; Pape HC; Budde T
    Neuropharmacology; 2007 Sep; 53(3):431-46. PubMed ID: 17675191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of ethosuximide on amino acids in genetic absence epilepsy rat model.
    Terzioğlu B; Aypak C; Onat FY; Küçükibrahimoğlu E; Ozkaynakçi AE; Gören MZ
    J Pharmacol Sci; 2006 Mar; 100(3):227-33. PubMed ID: 16538026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the action of the anti-absence drug ethosuximide in the rat and cat thalamus.
    Leresche N; Parri HR; Erdemli G; Guyon A; Turner JP; Williams SR; Asprodini E; Crunelli V
    J Neurosci; 1998 Jul; 18(13):4842-53. PubMed ID: 9634550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localized cortical injections of ethosuximide suppress spike-and-wave activity and reduce the resistance to kindling in genetic absence epilepsy rats (GAERS).
    Gülhan Aker R; Tezcan K; Carçak N; Sakalli E; Akin D; Onat FY
    Epilepsy Res; 2010 Mar; 89(1):7-16. PubMed ID: 19939632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of intracranial administration of ethosuximide in rats with spontaneous or pentylenetetrazol-induced spike-wave discharges.
    Chen SD; Yeh KH; Huang YH; Shaw FZ
    Epilepsia; 2011 Jul; 52(7):1311-8. PubMed ID: 21729038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting thalamic nuclei is not sufficient for the full anti-absence action of ethosuximide in a rat model of absence epilepsy.
    Richards DA; Manning JP; Barnes D; Rombola L; Bowery NG; Caccia S; Leresche N; Crunelli V
    Epilepsy Res; 2003 May; 54(2-3):97-107. PubMed ID: 12837561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of petit mal anticonvulsants and convulsants on thalamic neurones: GABA current blockade.
    Coulter DA; Huguenard JR; Prince DA
    Br J Pharmacol; 1990 Aug; 100(4):807-13. PubMed ID: 2119843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticonvulsant drug effects on spontaneous thalamocortical rhythms in vitro: ethosuximide, trimethadione, and dimethadione.
    Zhang YF; Gibbs JW; Coulter DA
    Epilepsy Res; 1996 Feb; 23(1):15-36. PubMed ID: 8925801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethosuximide modifies network excitability in the rat entorhinal cortex via an increase in GABA release.
    Greenhill SD; Morgan NH; Massey PV; Woodhall GL; Jones RS
    Neuropharmacology; 2012 Feb; 62(2):807-14. PubMed ID: 21945797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ETHOSUXIMIDE (ALPHA-ETHYL-ALPHA-METHYLSUCCINIMIDE) AND GRAND MAL.
    LORENTZDEHAAS AM; KUILMAN M
    Epilepsia; 1964 Mar; 5():90-6. PubMed ID: 14155210
    [No Abstract]   [Full Text] [Related]  

  • 15. Development of tolerance to the anticonvulsant effect of valproate but not to ethosuximide in a rat model of absence epilepsy.
    Wahle H; Frey HH
    Eur J Pharmacol; 1990 May; 181(1-2):1-8. PubMed ID: 2117539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of petit mal anticonvulsants and convulsants on thalamic neurones: calcium current reduction.
    Coulter DA; Huguenard JR; Prince DA
    Br J Pharmacol; 1990 Aug; 100(4):800-6. PubMed ID: 2169941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticonvulsants specific for petit mal antagonize epileptogenic effect of leucine enkephalin.
    Snead OC; Bearden LJ
    Science; 1980 Nov; 210(4473):1031-3. PubMed ID: 6254150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cortical-area specific block of genetically determined absence seizures by ethosuximide.
    Manning JP; Richards DA; Leresche N; Crunelli V; Bowery NG
    Neuroscience; 2004; 123(1):5-9. PubMed ID: 14667436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents.
    Brigo F; Igwe SC
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD003032. PubMed ID: 28195639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethosuximide converts ictogenic neurons initiating absence seizures into normal neurons in a genetic model.
    Polack PO; Charpier S
    Epilepsia; 2009 Jul; 50(7):1816-20. PubMed ID: 19260940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.